Horizon Therapeutics Ireland Designated Activity Company (DAC) – FDA Inspection, Dec 14, 2023

Record Details

This FDA Inspection record concerns Horizon Therapeutics Ireland Designated Activity Company (DAC), with an inspection on December 14, 2023, issued by the Office of Inspections and Investigations.

Company: Horizon Therapeutics Ireland Designated Activity Company (DAC)
Inspection Date: December 14, 2023
Office: Office of Inspections and Investigations
People: Madushini N. Dharmasena
Maria G. Gutierrez-Hoffman (Issuing Officer)

View Company Profile

ID · c020f20e-32f1-4742-ad6a-d0515ceaeb8f

Inspection Facts

Inspection number: 1238069
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Horizon Therapeutics Ireland Designated Activity Company (DAC)

FDA Inspection

Horizon Therapeutics Ireland Designated Activity Company (DAC)December 14, 2023

Horizon Therapeutics Ireland Designated Activity Company (DAC) – FDA Inspection, Dec 14, 2023

Record Details

This FDA Inspection record concerns Horizon Therapeutics Ireland Designated Activity Company (DAC), with an inspection on December 14, 2023, issued by the Office of Inspections and Investigations.